← Leaderboards
Ricardo Azziz
University Of Alabama At Birmingham
$5,301,766
Attributed
$5,301,766
Total exposure
18
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $940K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$5,301,766 · 18
By mechanism
R01$4,046,362 · 2
M01$617,805 · 13
K24$454,599 · 1
R03$153,000 · 1
R13$30,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Ji-Bin Peng$3,908,914
Others in their field
Top investigators on “Androgens”
- Shalendar Bhasin · La Biomed Res Inst/ Harbor Ucla Med Ctr$36,153,267
- Charles L Sawyers · Sloan-Kettering Inst Can Research$24,511,314
- Susan E. Hankinson · University Of Massachusetts Amherst$24,278,267
- Brian E Henderson · University Of Southern California$20,677,861
- Cory Abate-Shen · Columbia University Health Sciences$20,094,849
- Diane E Merry · Thomas Jefferson University$17,810,180
Research focus
AndrogensPolycystic Ovary SyndromeInsulinClinical ResearchResearch PersonnelWomanFundingFemaleHuman SubjectDefectAdrenal GlandsInsulin ResistanceReproductiveAffectResponseOvarianPhenotypeProgramsUnited States National Institutes Of HealthAdrenal DisorderPathway InteractionsHyperinsulinismHormone Regulation /Control MechanismPlay
Grant awards (49)
Adrenal Androgen Excess in PCOS: Role of Genetics$228,685
R01 · FY2011 · HD · contact PI
INSULIN SIGNALING DEFECTS IN PCOS$230,441
R01 · FY2010 · DK · contact PI
INSULIN SIGNALING DEFECTS IN PCOS$196,172
R01 · FY2010 · DK · contact PI
Adrenal Androgen Excess in PCOS: Role of Genetics$143,567
R01 · FY2010 · HD · contact PI
Adrenal Androgen Excess in PCOS: Role of Genetics$113,576
R01 · FY2010 · HD · contact PI
INSULIN SIGNALING DEFECTS IN PCOS$80,178
R01 · FY2010 · DK · contact PI
INSULIN SIGNALING DEFECTS IN PCOS$63,708
R01 · FY2010 · DK · contact PI
CENTER FOR ANDROGEN RELATED DISORDERS: CLINICAL DATA REPOSITORY FOR PATIENTS$63,584
M01 · FY2010 · RR · contact PI
Insulin Signaling Defects in PCOS$48,752
R01 · FY2010 · DK · contact PI
Adrenal Androgen Excess in PCOS: Role of Genetics$313,768
R01 · FY2009 · HD · contact PI
INSULIN SIGNALING DEFECTS IN PCOS$310,168
R01 · FY2009 · DK · contact PI
CENTER FOR ANDROGEN RELATED DISORDERS: CLINICAL DATA REPOSITORY FOR PATIENTS$61,429
M01 · FY2009 · RR · contact PI
Annual Meeting of the Androgen Excess Society$6,000
R13 · FY2009 · HD · contact PI
Adrenal Androgen Excess in PCOS: Role of Genetics$313,759
R01 · FY2008 · HD · contact PI
INSULIN SIGNALING DEFECTS IN PCOS$310,168
R01 · FY2008 · DK · contact PI
CENTER FOR ANDROGEN RELATED DISORDERS: CLINICAL DATA REPOSITORY FOR PATIENTS$19,006
M01 · FY2008 · RR · contact PI
MOLECULAR DEFECTS OF INSULIN SIGNALING IN PCOS$19,006
M01 · FY2008 · RR · contact PI
Annual Meeting of the Androgen Excess Society$6,000
R13 · FY2008 · HD · contact PI
Adrenal Androgen Excess in PCOS: Role of Genetics$320,243
R01 · FY2007 · HD · contact PI
INSULIN SIGNALING DEFECTS IN PCOS$316,497
R01 · FY2007 · DK · contact PI
PHARMACOGENETICS OF INSULIN RESISTANCE IN PCOS$12,240
M01 · FY2007 · RR · contact PI
Annual Meeting of the Androgen Excess Society$6,000
R13 · FY2007 · HD · contact PI
CENTER FOR ANDROGEN RELATED DISORDERS: CLINICAL DATA REPOSITORY FOR PATIENTS$5,758
M01 · FY2007 · RR · contact PI
MOLECULAR DEFECTS OF INSULIN SIGNALING IN PCOS$4,680
M01 · FY2007 · RR · contact PI
INSULIN SIGNALING DEFECTS IN PCOS$325,950
R01 · FY2006 · DK · contact PI
INSULIN RESISTANCE IN PCOS$12,467
M01 · FY2006 · RR · contact PI
Annual Meeting of the Androgen Excess Society$6,000
R13 · FY2006 · HD · contact PI
PHARMACOGENETICS OF INSULIN RESISTANCE IN PCOS$1,870
M01 · FY2006 · RR · contact PI
INSULIN RESISTANCE IN PCOS$8,195
M01 · FY2005 · RR
Annual Meeting of the Androgen Excess Society$6,000
R13 · FY2005 · HD
ANDROGEN EXCESS DISORDER$94,753
K24 · FY2004 · HD
Molecular Defects of Insulin Signaling in PCOS$76,500
R03 · FY2004 · HD
ANDROGEN EXCESS DISORDER$92,780
K24 · FY2003 · HD
Molecular Defects of Insulin Signaling in PCOS$76,500
R03 · FY2003 · HD
SERINE PHOSPHORYLATION OF P450C17 &5 ALPHA REDUCTASE ACTIVITY$175,256
M01 · FY2002 · RR
ADRENAL ANDROGEN EXCESS IN THE POLYCYSTIC OVARY SYNDROME$171,127
R01 · FY2002 · HD
ANDROGEN EXCESS DISORDER$90,000
K24 · FY2002 · HD
ADRENAL ANDROGEN EXCESS IN THE POLYCYSTIC OVARY SYNDROME$73,042
R01 · FY2002 · HD
ANDROGEN EXCESS DISORDER$864
K24 · FY2002 · HD
INSULIN TOLERANCE IN HEALTHY AND HYPERANDRONGENIC WOMEN$0
M01 · FY2002 · RR
ADRENAL ANDROGEN EXCESS IN THE POLYCYSTIC OVARY SYNDROME$232,659
R01 · FY2001 · HD
SERINE PHOSPHORYLATION OF P450C17 &5 ALPHA REDUCTASE ACTIVITY$175,256
M01 · FY2001 · RR
ANDROGEN EXCESS DISORDER$89,004
K24 · FY2001 · HD
INSULIN TOLERANCE IN HEALTHY AND HYPERANDRONGENIC WOMEN$0
M01 · FY2001 · RR
ADRENAL ANDROGEN EXCESS IN THE POLYCYSTIC OVARY SYNDROME$253,902
R01 · FY2000 · HD
ANDROGEN EXCESS DISORDER$87,198
K24 · FY2000 · HD
SERINE PHOSPHORYLATION OF P450C17 &5 ALPHA REDUCTASE ACTIVITY$29,529
M01 · FY2000 · RR
INSULIN TOLERANCE IN HEALTHY AND HYPERANDRONGENIC WOMEN$29,529
M01 · FY2000 · RR
INSULIN REDUCTION AND OVULATORY RATES IN WOMEN W PCOS$0
M01 · FY2000 · RR